Colorectal cancer screening in the Czech Republic after the implementation of personalised invitations – preliminary results according to available data

Česká verzia

Authors: L. Dušek ¹; O. Májek ¹; Š. Suchánek ²; B. Seifert ³; M. Zavoral ²
Authors place of work: Institut biostatistiky a analýz, LF MU, Brno ¹; Interní klinika ÚVN – VFN Praha ²; 1. LF UK, Praha ³
Published in the journal: Gastroent Hepatol 2014; 68(5): 401-407
Category: Gastrointestinal Oncology: Original Article
doi: https://doi.org/10.14735/amgh2014401

Summary

The Czech Republic ranks among countries with the highest colorectal cancer incidence and mortality both in Europe and worldwide. The Czech colorectal screening program has sufficient capacity and is guaranteed by all relevant medical specialties, i.e., general practitioners, gastroenterologists, and gynecologists. However, current coverage of the target population reaches just 25%. In January 2014, a program of personalized invitations was launched in the Czech Republic. The project is coordinated by the Czech Ministry of Health in cooperation with the relevant expert medical societies, representatives of health care payers, and other experts nominated by the Minister of Health. This article describes the methodology of personalized invitations which has been implemented nationwide, its data background, and the preliminary results of the project from the first half of 2014, when almost one million Czech citizens were invited to the colorectal cancer screening program.

Key words:
malign tumor – colon – rectum – prevention – screening – personalized invitation

The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE „uniform requirements“ for biomedical papers.

Submitted:
4. 9. 2014

Accepted:
3. 10. 2014

Zdroje

1. Ferlay J, Soerjomataram I, Ervik M et al. GLOBOCAN 2012: estimated cancer incidence and mortality worldwide in 2012. International Agency for Research on Cancer. [online]. Available from: http://globocan.iarc.fr.

2. Epidemiologie zhoubných nádorů v České republice. [online]. Dostupné z: http://www.svod.cz.

3. Dušek L (ed.). Czech cancer care in numbers 2008–2009. Praha: Grada Publishing 2009.

4. Pavlík T, Májek O, Mužík J et al. Estimating the number of colorectal cancer patients treated with anti-tumour therapy in 2015: the analysis of the Czech National Cancer Registry. BMC Public Health 2012; 12: 117. doi: 10.1186/1471-2458-12-117.

5. Bond JH. Fecal occult blood testing for colorectal cancer. Can we afford not to do this? Gastroenterol Clin North Am 1997; 26(1): 57–70.

6. Hewitson P, Glasziou P, Watson E et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008; 103(6): 1541–1549. doi: 10.1111/j.1572-0241.2008.01875.x.

7. Brenner H, Hoffmeister M, Brenner G et al. Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: estimates based on 1,875,708 screening colonoscopies. Eur J Cancer 2009; 45(11): 2027–2033. doi: 10.1016/j.ejca.2009.02.017.

8. Zauber AG, Winawer SJ, O'Brien MJ et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012; 366(8): 687–696. doi: 10.1056/NEJMoa1100370.

9. Zavoral M, Suchánek S, Májek O et al. Population screening of colorectal carcinoma in the Czech Republic. Rozhl Chir 2009; 88(6): 292–294.

10. Frič P, Zavoral M. Screening kolorektálního karcinomu: projekce zahraničních zkušeností – jak se lze poučit, jak dále? Prakt Lék 2002; 82(4): 203–204.

11. Zavoral M, Suchánek S, Závada F et al. Colorectal cancer screening in Europe. World J Gastroenterol 2009; 15(47): 5907–5915.

12. The Council of the European Union. Council recommendation of 2 December 2003 on cancer screening (2003/878/EC). Off J Eur Union 2003; 327: 34–38.

13. Poc P, Brepoels F, Busoi CC et al. Written declaration on fighting colorectal cancer in the European Union. The European Parliament PE449.546v01-00. 20. 12. 2010.

14. Karsa L, Anttila A, Ronco G et al. Cancer screening in the European Union: report on the implementation of the Council Recommendation on cancer screening. Luxembourg: European Communities 2008.

15. Prorok P, Kramer B, Gohagan J. Screening theory and study design: the basics. In: Kramer B, Gohagan J, Prorok P (eds). Cancer screening – theory and practice. New York: Marcel Dekker 1999: 29–53.

16. Segnan N, Patnick J, Karsa L. European guidelines for quality assurance in colorectal cancer screening and diagnosis. 1. ed. Luxembourg: Publications Office of the European Union 2010.

17. Miles A, Cockburn J, Smith RA et al. A perspective from countries using organized screening programs. Cancer 2004; 101 (5 Suppl): 1201–1213.

18. Weller D, Coleman D, Robertson R et al. The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer 2007; 97(12): 1601–1605.

19. UK Colorectal Cancer Screening Pilot Group. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ 2004; 329(7458): 133.

20. Denis B, Ruetsch M, Strentz P et al. Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test. Gut 2007; 56(11): 1579–1584.

21. Hol L, van Leerdam ME, van Ballegooijen M et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010; 59(1): 62–68. doi: 10.1136/gut.2009.177089.

22. Steele RJ, McClements PL, Libby G et al. Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut 2009; 58(4): 530–535. doi: 10.1136/gut.2008.162883.

23. Peris M, Espinas JA, Muñoz L et al. Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain). J Med Screen 2007; 14(2): 81–86.

24. Logan RF, Patnick J, Nickerson C et al. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut 2012; 61(10): 1439–1446.

25. Malila N, Palva T, Malminiemi O et al. Coverage and performance of colorectal cancer screening with the faecal occult blood test in Finland. J Med Screen 2011; 18(1): 18–23. doi: 10.1258/jms.2010.010036.

26. Malila N, Oivanen T, Malminiemi O et al. Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design. BMJ 2008; 337: a2261. doi: 10.1136/bmj.a2261.

27. Malila N, Anttila A, Hakama M. Colorectal cancer screening in Finland: details of the national screening programme implemented in Autumn 2004. J Med Screen 2005; 12(1): 28–32.